April 29, 2017 3:00 PM ET

Capital Markets

Company Overview of Hellman & Friedman LLC

Company Overview

Hellman & Friedman LLC is a private equity firm specializing in leveraged recapitalizations, acquisitions, buys and builds, traditional buyouts, financial restructurings, growth investments, and numerous types of minority investments. It invests in public and private companies. The firm makes investments in marketing and professional services, asset management and other business and financial services, insurance, media, energy, healthcare, companies running clinical trials for pharmaceutical companies, industrials, vertical software and information services industries, data services, Internet and digital media, and media. It targets investments in companies based in North America with a focu...

One Maritime Plaza

12th Floor

San Francisco, CA 94111

United States

Founded in 1984





Key Executives for Hellman & Friedman LLC

Chief Executive Officer, Managing Director, Chairman of Investment Committee, and Chairman of Compensation Committee
Age: 48
Managing Director and Chief Financial Officer
Managing Director and Chief Legal Officer
Managing Director, Deputy Chief Executive Officer, Member of Compensation Committee, and Member of Investment Committee
Age: 49
Managing Director and Member of Investment Committee
Compensation as of Fiscal Year 2016.

Hellman & Friedman LLC Key Developments

Carlyle And Hellman & Friedman Reportedly In Talks To Sell Stake In PPD

The Carlyle Group LP (NasdaqGS:CG) and Hellman & Friedman LLC are in talks to sell minority stakes in Pharmaceutical Product Development, LLC to investors that include Abu Dhabi Investment Authority and GIC Pte. Ltd., the people said. Carlyle and Hellman & Friedman would continue to collectively own more than half the company, the people added. The exact deal structure is still being hammered out, and negotiations are expected to continue for much of April, with no certainty that a deal will be reached, the people added.

Private Equity Fund Reportedly Seeks Acquisition Of Zabka Polska From Mid Europa Partners

Private equity fund reportedly are seeking acquisition of Zabka Polska sp. z o.o. from Mid Europa Partners LLP. Puls Biznesu daily reported that the private equity funds want to buy Zabka Polska from Mid Europa Partners. The first bids were filed on December 19, 2016. Among the funds interested in the issue are TPG Capital, L.P., BC Partners, Hellman & Friedman LLC and CVC Capital Partners Limited. Apart from them, CP ALL Public Company Limited (SET:CPALL) is mentioned among the prospective buyers A source of Puls Biznesu claims that PLN 5 billion is regarded as a starting point in negotiations with the prospective investor.

Pharmaceutical Product Development Reportedly Exploring Sale

Pharmaceutical Product Development, LLC is reportedly exploring sale. Pharmaceutical Product Development LLC is exploring a sale that could value the drug-research company at about $5 billion. Pharmaceutical Product Development hired The Goldman Sachs Group, Inc. (NYSE:GS), J.P. Morgan Chase & Co. and Centerview Partners LLC to help it find a buyer, people familiar with the matter said. The banks plan to start sounding out suitors in December. A deal could be reached in the first quarter, assuming there is one, the people said. Pharmaceutical Product Development’s owners, The Carlyle Group LP (NasdaqGS:CG) and Hellman & Friedman LLC, may opt to take it public instead, but they aren’t actively preparing for an IPO, the people said. A $5 billion deal would deliver a return of more than three times the firms’ investment, when accounting for four dividends PPD has paid them.

Similar Private Companies By Industry

Company Name Region
@Visory LLC United States
1 Road Partners LLC United States
11T Partners, LLC United States
123Jump.com, Inc. United States
1509225 Ontario, Inc. United States

Recent Private Companies Transactions

Private Placement
April 26, 2017
Pharmaceutical Product Development, LLC
March 7, 2017
Allfunds Bank S.A.
July 21, 2016
Genesys Telecommunications Laboratories, Inc.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Hellman & Friedman LLC, please visit www.hf.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.